Typical dosage: Oral for GI applications: 500 to 1,500 mcg per day, in one or two divided doses Subcutaneous for systemic anti-inflammatory effects: 200 to 500 mcg per day Oral is preferred for IBD/colitis applications due to PepT1-mediated intestinal targeting Cycle length: 4 to 8 weeks Limitations: No human clinical trials have been completed for KPV in any GI indication
NNMT inhibitors display high membrane permeability Compounds spanning ~100-fold IC 50 values for NNMT inhibition were selected on the basis of positional substitutions around the N-methylated quinolinium scaffold[17] to obtain an estimate of drug-like oral absorption/bioavailability properties and guide the choice of inhibitors for in vitro and in vivo phenotypic studies
It binds to copper, an essential mineral for healthy tissue, and helps increase collagen and elastin production, improve blood flow, and protect cells from damage
No standardised human research protocol exists
These abrupt changes in antidiuretic hormone (ADH) secretion from the posterior pituitary gland can lead to large water diuresis 4,11
Third, patients with a personal cancer history, active autoimmune disease, pregnancy or planned pregnancy, or who take anticoagulants, antipsychotics, or antidepressants should not use BPC-157 until prospective human trial data characterize safety in those populations
